Utility of posaconazole therapeutic drug monitoring and assessment of plasma concentration threshold for effective prophylaxis of invasive fungal infections: a meta-analysis with trial sequential analysis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Utility of posaconazole therapeutic drug monitoring and assessment of plasma concentration threshold for effective prophylaxis of invasive fungal infections: a meta-analysis with trial sequential analysis
Authors
Keywords
Posaconazole, Prophylaxis, Target plasma concentration, Invasive fungal infections, Therapeutic drug monitoring
Journal
BMC INFECTIOUS DISEASES
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-04-04
DOI
10.1186/s12879-018-3055-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy, safety and feasibility of antifungal prophylaxis with posaconazole tablet in paediatric patients after haematopoietic stem cell transplantation
- (2017) Michaela Döring et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Retrospective analysis of goal drug level attainment of posaconazole for invasive fungal infection prophylaxis in patients with acute myeloid leukemia pre- and post-switch to tablet formulation
- (2017) Tyler K Liebenstein et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
- (2016) Thomas F. Patterson et al. CLINICAL INFECTIOUS DISEASES
- Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
- (2016) Peter G. Pappas et al. CLINICAL INFECTIOUS DISEASES
- A pharmacokinetic analysis of posaconazole oral suspension in the serum and alveolar compartment of lung transplant recipients
- (2016) L. Thakuria et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Effectiveness of increasing the frequency of posaconazole syrup administration to achieve optimal plasma concentrations in patients with haematological malignancy
- (2016) Wan Beom Park et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Utility of voriconazole therapeutic drug monitoring: a meta-analysis
- (2016) Me-Linh Luong et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Trough concentration of voriconazole and its relationship with efficacy and safety: a systematic review and meta-analysis
- (2016) Haiying Jin et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacokinetics of Posaconazole Oral Suspension in Children Dosed According to Body Surface Area
- (2016) Kim Vanstraelen et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- The Association between Sulfonylurea Use and All-Cause and Cardiovascular Mortality: A Meta-Analysis with Trial Sequential Analysis of Randomized Clinical Trials
- (2016) Dimitris Varvaki Rados et al. PLOS MEDICINE
- Posaconazole Substitution for Voriconazole-Associated Phototoxic Effects
- (2016) Audrey A. Jacobsen et al. JAMA Dermatology
- Network Meta-analysis and Pharmacoeconomic Evaluation of Fluconazole, Itraconazole, Posaconazole, and Voriconazole in Invasive Fungal Infection Prophylaxis
- (2015) Ying Jiao Zhao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Determination of posaconazole concentration with LC–MS/MS in adult patients with hematologic malignancy
- (2015) Hyojin Chae et al. CLINICA CHIMICA ACTA
- Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease
- (2015) Oliver A. Cornely et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Therapeutic Drug Monitoring and Dose Adjustment of Posaconazole Oral Suspension in Adults With Acute Myeloid Leukemia
- (2015) Shelly E. Hummert et al. THERAPEUTIC DRUG MONITORING
- Posaconazole liquid suspension in solid organ transplant recipients previously treated with voriconazole
- (2015) S. Shoham et al. Transplant Infectious Disease
- Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology
- (2014) Daniela Tacke et al. ANNALS OF HEMATOLOGY
- Phase 1b Study of New Posaconazole Tablet for Prevention of Invasive Fungal Infections in High-Risk Patients with Neutropenia
- (2014) Rafael F. Duarte et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phase 1B Study of the Pharmacokinetics and Safety of Posaconazole Intravenous Solution in Patients at Risk for Invasive Fungal Disease
- (2014) Johan Maertens et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation
- (2014) Andreas H Groll et al. LANCET ONCOLOGY
- Factors influencing posaconazole plasmatic concentrations in patients presenting with acute myeloid leukemia
- (2014) P.-Y. Desplanques et al. MEDECINE ET MALADIES INFECTIEUSES
- Posaconazole prophylaxis in neutropenic patients with hematological malignancies: limits in clinical practice
- (2014) Magali Bourdelin et al. MEDICAL MYCOLOGY
- Recent advances in the treatment of life-threatening, invasive fungal infections
- (2013) Richard H Drew et al. EXPERT OPINION ON PHARMACOTHERAPY
- Posaconazole Therapeutic Drug Monitoring in the Real-life Setting: A Single-Center Experience and Review of the Literature
- (2013) Barbara N. Gross et al. PHARMACOTHERAPY
- Efficacy of Anti-Leishmania Therapy in Visceral Leishmaniasis among HIV Infected Patients: A Systematic Review with Indirect Comparison
- (2013) Gláucia F. Cota et al. PLoS Neglected Tropical Diseases
- Therapeutic Drug Monitoring of Posaconazole in Allogeneic Hematopoietic Stem Cell Transplantation Patients Who Develop Gastrointestinal Graft-versus-Host Disease
- (2012) J. Tonini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Study of Posaconazole Therapeutic Drug Monitoring: Exposure-Response Relationship and Factors Affecting Concentration
- (2012) Michael J. Dolton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of an alternative posaconazole prophylaxis regimen in haematological malignancy patients receiving concomitant stress ulcer prophylaxis
- (2012) Ashley L. Ross et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Posaconazole plasma concentrations and invasive mould infections in patients with haematological malignancies
- (2012) Martin Hoenigl et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Posaconazole after previous antifungal therapy with voriconazole for therapy of invasive aspergillus disease, a retrospective analysis
- (2012) Werner J. Heinz et al. MYCOSES
- ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients
- (2011) O Marchetti et al. BONE MARROW TRANSPLANTATION
- Therapeutic drug monitoring of posaconazole in hematology adults under posaconazole prophylaxis: influence of food intake
- (2011) C. Eiden et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- A post-marketing evaluation of posaconazole plasma concentrations in neutropenic patients with haematological malignancy receiving posaconazole prophylaxis
- (2011) Alexander M. Bryant et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A Twice Daily Posaconazole Dosing Algorithm for Children With Chronic Granulomatous Disease
- (2011) Marieke E. B. Welzen et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Posaconazole Serum Concentrations among Cardiothoracic Transplant Recipients: Factors Impacting Trough Levels and Correlation with Clinical Response to Therapy
- (2010) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Exposure–Response of Posaconazole Used for Prophylaxis Against Invasive Fungal Infections: Evaluating the Need to Adjust Doses Based on Drug Concentrations in Plasma
- (2010) S H Jang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Therapeutic Drug Monitoring of Posaconazole: a Monocentric Study with 54 Adults
- (2009) D. Lebeaux et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Intrapulmonary Pharmacokinetics and Pharmacodynamics of Posaconazole at Steady State in Healthy Subjects
- (2008) J. E. Conte et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications
- (2008) D. Andes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
- (2008) Ben De Pauw et al. CLINICAL INFECTIOUS DISEASES
- Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?
- (2008) Kristian Thorlund et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Apparently conclusive meta-analyses may be inconclusive—Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses
- (2008) Jesper Brok et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Pharmacokinetics of Oral Posaconazole in Neutropenic Patients Receiving Chemotherapy for Acute Myelogenous Leukemia or Myelodysplastic Syndrome
- (2008) Gopal Krishna et al. PHARMACOTHERAPY
- Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis
- (2007) Jørn Wetterslev et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started